Extracellular vesicles and lupus nephritis - New insights into pathophysiology and clinical implications

Yin Zhao,Wei Wei,Ming-Lin Liu

DOI: https://doi.org/10.1016/j.jaut.2020.102540

IF: 14.511

2020-12-01

Journal of Autoimmunity

Abstract:<p>Lupus nephritis (LN) is a major cause for overall morbidity and mortality in patients with systemic lupus erythematosus (SLE), while its pathogenic mechanisms are still not well understood. Extracellular vesicles (EVs) are membrane vesicles that are released from almost all cell types. EVs can be subdivided into exosomes, microvesicles, and apoptotic bodies. Latest studies have shown that EVs can be released during several cellular events, including cell activation, autophagy, and several types of programed cell death, i.e. apoptosis, necroptosis, pyroptosis, and NETosis. Emerging evidence demonstrates that EVs harbor different bioactive molecules, including nucleic acids, proteins, lipids, cytokines, immune complexes (ICs), complements, and other molecules, some of which may contribute to pathogenesis of autoimmune diseases. EVs can serve as novel information shuttle to mediate local autocrine or paracrine signals to nearby cells, and distant endocrine signals to cells located far away. In LN, EVs may have pathogenic effects by transportation of autoantigens or complements, promotion of IC deposition or complement activation, and stimulation of inflammatory responses, renal tissue injury, or microthrombus formation. Additionally, EVs released from kidney cells may serve as specific biomarkers for diagnosis or monitoring of disease activity and therapeutic efficacy. In this review, we will summarize the latest progress about EV generation from basic research, their potential pathologic effects on LN, and their clinical implications. The cutting-edge knowledge about EV research provides insights into novel therapeutic strategy, new tools for diagnosis or prognosis, and evaluation approaches for treatment effectiveness in LN.</p>

immunology

What problem does this paper attempt to address?

This paper attempts to explore the pathophysiological mechanisms and clinical significance of extracellular vesicles (EVs) in lupus nephritis (LN). Specifically, the paper focuses on the following aspects:

1. **EVs as a source of autoantigens**: The paper discusses how intracellular molecules are redistributed to the cell membrane surface during apoptosis, pyroptosis, necroptosis, etc., and become potential autoantigens with the release of EVs. These autoantigens may trigger B cells to produce autoantibodies, form immune complexes (ICs), which are then deposited in the kidneys, leading to the occurrence of LN.

2. **Deposition of EVs and immune complexes in the glomerulus**: The paper points out that EVs can carry immunoglobulins and complement components to form EV - containing immune complexes (EV - ICs). These EV - ICs interact with negatively charged molecules on the glomerular basement membrane (GBM), such as heparan sulfate proteoglycan (HSPG), to promote their deposition in the glomerulus, thereby causing an inflammatory response and tissue damage.

3. **EVs carry or activate the complement system**: The paper mentions that EVs can not only directly carry multiple complement components but also activate the complement system through the classical or alternative pathways. This activation may lead to endothelial cell damage, exacerbation of the inflammatory response, and further damage to renal tissue.

4. **Contribution of EVs to the inflammatory response and pro - coagulant state**: The paper also explores how EVs carry pro - inflammatory factors (such as cytokines, inflammasomes, adhesion molecules, leukotrienes, etc.), further propagate the inflammatory response, and promote the formation of micro - thrombi by carrying pro - coagulant properties (such as phosphatidylserine - positive EVs and tissue factor - positive EVs), aggravating the condition of LN.

In summary, this paper aims to comprehensively summarize the multiple roles of EVs in the pathogenesis of LN, including as a source of autoantigens, participating in the deposition of immune complexes, activating the complement system, and promoting the inflammatory response and pro - coagulant state, providing new ideas and tools for the diagnosis, treatment, and prognosis evaluation of LN.